Clinical Trials Logo

Blindness clinical trials

View clinical trials related to Blindness.

Filter by:

NCT ID: NCT00795236 Terminated - Sleep Disorder Clinical Trials

Melatonin Studies of Totally Blind Children

Start date: November 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to learn more about abnormal body rhythms in blind boys and girls that keep them from falling asleep at bed-time or cause them difficulty staying alert during the day. The investigators hope to learn if there are any differences between the body rhythms of girls and boys. The investigators also want to investigate whether age or puberty have an effect on body rhythms.

NCT ID: NCT00749957 Completed - Clinical trials for Leber Congenital Amaurosis

Phase 1/2 Safety and Efficacy Study of AAV-RPE65 Vector to Treat Leber Congenital Amaurosis

Start date: June 17, 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of the study is to evaluate the safety and efficacy of an adeno-associated virus vector expressing RPE65 in patients with Leber congenital amaurosis caused by mutations in the RPE65 gene. Funding Source - FDA OOPD

NCT ID: NCT00692094 Terminated - Blindness Clinical Trials

Blind Elderly Melatonin Treatment Study

Start date: August 2004
Phase: N/A
Study type: Interventional

The primary focus of this five-year study will be to optimize the melatonin dosing regimen for synchronizing the body clocks of elderly blind individuals to the 24-hour day.

NCT ID: NCT00691444 Terminated - Blindness Clinical Trials

Blind Child Melatonin Treatment Study

Start date: September 2002
Phase: N/A
Study type: Interventional

The primary focus of this five-year study will be to optimize the melatonin dosing regimen for synchronizing the body clocks of blind children to the 24-hour day.

NCT ID: NCT00688935 Terminated - Blindness Clinical Trials

Young Blind Child Melatonin Treatment Study

Start date: January 2005
Phase: N/A
Study type: Interventional

The primary goal of this study is to identify the presence of desynchronized circadian rhythms in 25 children by measuring melatonin secretion in serial blood or saliva samples, and to rule out any primary sleep disorders.

NCT ID: NCT00686907 Active, not recruiting - Blindness Clinical Trials

Blind Adult Melatonin Treatment Study

Start date: March 2007
Phase: N/A
Study type: Interventional

The primary two foci of this five-year study will be to assess inter-individual variability in the timing of the body clock of blind individuals, and to optimize the melatonin dosing regimen for synchronizing body clocks of blind individuals to the 24-hour day.

NCT ID: NCT00634972 Terminated - Clinical trials for Retinopathy of Prematurity

Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity

ROP
Start date: November 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to test whether ACULAR, a nonsteroidal anti-inflammatory eye drop medication, can prevent the development of retinopathy of prematurity (ROP) and/ or decrease its severity.In this study ACULAR will be compared to a placebo (artificial tear). The hypothesis would be that ACULAR treatment will decrease the incidence of moderate to severe ROP (grade II and above)by 50%.

NCT ID: NCT00589407 Terminated - Neck Pain Clinical Trials

Unilateral Blindness/ Unilateral Deafness-relation to Neck Pain

Start date: n/a
Phase: N/A
Study type: Observational

Neck pain is a common complaint in the general population affecting 10-15% of the general population. females more than men. Known risk factors are: Trauma, Repetitive lifting of heavy objects at work, driving vibrating vehicles, frequents diving from boards and smoking. No study dealt with the possible role of unilateral loss of vision or hearing as a risk factor for the development of neck pain. Intuitively, one might suspect that unilateral blindness or deafness will lead to a tilted position of the head, in order to cover a better visual/audio field. This position, in time, might lead to the development of neck pain. Our hypothesis is that patients with unilateral blindness/deafness will suffer from neck pain more frequently than the general population.

NCT ID: NCT00569023 Completed - Night Blindness Clinical Trials

Treatment of Congenital Stationary Night Blindness With an Alga Containing High Dose of Beta Carotene

Start date: July 2007
Phase: N/A
Study type: Interventional

To assess the effect of oral administration of the alga Dunaliella bardawil containing approximately 50% all-trans beta-carotene and 50% 9-cis beta-carotene isomers on visual functions patients with Congenital Stationary Night Blindness {Fundus albipunctatus).

NCT ID: NCT00516477 Completed - Clinical trials for Leber Congenital Amaurosis

Safety Study in Subjects With Leber Congenital Amaurosis

Start date: September 2007
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine whether gene transfer will be safe and effective in the treatment of Leber Congenital Amaurosis (LCA).